Skip Navigation

Visiting Dana-Farber? See our prescreening and mask requirements.

Genitourinary Cancer Treatment Center

About the Genitourinary Cancer Treatment Center

  • Dana-Farber’s Lank Center for Genitourinary Oncology provides compassionate care and the most effective therapies for prostate, kidney, bladder, and testicular cancer, as well as many other rare and common cancers. Staffed by medical, urologic, and radiation oncologists, our center offers the latest treatments fueled by ongoing discovery.

    At the Lank Center, we want our patients to receive the safest, best treatment for their cancer. Our center provides compassionate care that is informed by research into the most effective therapies.

    We know you face challenges that extend into family, work, and other responsibilities. That knowledge guides how our team of specialists works with you to create a care plan that takes your individual goals and needs into account.

    genitourinary cancer clinicians with a patient

    Our team will build a treatment plan tailored to your cancer, based on the latest surgical, chemotherapy, targeted therapy, and/or radiation treatment approaches, including access to clinical trials.

    In addition to offering the latest in clinical care, we provide a wide range of resources — from support groups to nutritional advice to complementary therapies — to support you physically and emotionally throughout your treatment.

    We also offer Patient Navigation, which can assist you as you move through the cancer care continuum. Patient Navigation can help with arranging various forms of financial support, scheduling transportation to and from appointments, organizing child care during appointments, and more. Our GU Patient Navigator provides education about prostate cancer and treatment options, and upon request, will sit with you before, during and after your consultations with our clinicians.

  • New Patient Appointments
    877-442-3324

    Make Appointment Online
    Dana-Farber Brigham Cancer Center logo
    US News adult badge - smaller

  • Center for BRCA and Related Genes

    Mutations in BRCA1, BRCA2, and BRCA-related genes confer increased risk of certain cancers when inherited. These mutations can also be acquired by the cancers themselves. The Center for BRCA and Related Genes provides comprehensive care for patients with inherited and acquired mutations, including clinical therapeutic trials, trials of risk-reducing strategies, and studies of novel early detection markers.

  • new patient coordinators

    Becoming a Patient

    As a new Dana-Farber patient, find answers to questions about your first visit: what to bring, how to find us, where to park, and how to prepare.

    cover supportive resources brochure

    Support Services and Amenities

    We offer a wide range of services, from financial planning to creative arts to spiritual counsel, to support our patients through their cancer experiences.

    patient rating stars

    How Our Patients Rate Dana-Farber

    See patient satisfaction survey results for different Dana-Farber locations collected by Press Ganey, an independent company experienced in patient satisfaction surveying.

  • Blum Center creative arts program participant

    The Eleanor and Maxwell Blum Patient and Family Resource Center

    The Blum Resource Center provides patients and family members with a comfortable environment to learn more about disease treatment and management.

    fresh fruit and vegetables

    Nutrition Services

    Our nutrition experts help patients follow a healthy diet during and after cancer treatment.

    Join Cancer Connect

    Join Our Online Cancer Community

    Join Dana-Farber's online cancer community and connect with other patients and survivors for support and information.

  • Read Our Genitourinary Patients' Stories

    Retiring after several decades in financial services, Rubin enjoyed his "second career" running a hot dog cart for several years despite various health challenges.
    Insight Blog
    9/7/2023

    ​​​Retiree Relishing Life After Advanced Kidney Cancer Treatment 

    • Patient Stories, Adult
    • Kidney Cancer
    • Genitourinary Cancer
    Chuck Stravin (standing, upper right) and wife Liz (kneeling, in black) celebrate the big day with daughters MaryBeth, Meghan, and Colleen (in red, left to right), daughter and son-in-law Kayla and Jimmy McMahon (center), and family goldendoodle Quinn Stravin.
    Insight Blog
    4/4/2023

    Father with Stage IV Kidney Cancer Enjoys Wedding of a Lifetime

    • Patient Stories, Adult
    • Kidney Cancer
    • Genitourinary Cancer
    Joshua Kraft, president of the New England Patriots Charitable Foundation Photo Credit: New England Patriots
    News Releases
    3/29/2023

    Joshua Kraft advocates for prostate cancer screening as he announces he has been treated for the disease

    • Patient Stories, Adult
    • Prostate Cancer
    Insight Blog
    1/30/2023

    Metastatic Prostate Cancer Can’t Slow Down Grandfather

    • Patient Stories, Adult
    • Prostate Cancer
    • Genitourinary Cancer
    Fredrick Knight and his wife, Kate.
    Insight Blog
    1/3/2023

    Young Testicular Cancer Patient in Remission Pays It Forward

    • Patient Stories, Adult
    • Testicular Cancer
    • Genitourinary Cancer
    Insight Blog
    8/2/2021

    Study Pairs Two Forms of Immunotherapy in Patients with Advanced Kidney Cancer

    • Patient Stories, Adult
    • Kidney Cancer
    • Genitourinary Cancer
    Insight Blog
    3/11/2021

    Newly FDA-Approved Therapy Offers Kidney Cancer Patient a Path Forward

    • Patient Stories, Adult
    • Kidney Cancer
    • Genitourinary Cancer
    Insight Blog
    12/9/2019

    Nobel Prize Research Was a Winning Formula for Patient with Kidney Cancer

    • Research
    • Patient Stories, Adult
    • Kidney Cancer
    • Genitourinary Cancer
    Insight Blog
    9/17/2019

    Prostate Cancer Patient Thriving 17 Years After Diagnosis

    • Patient Stories, Adult
    • Prostate Cancer
    • Genitourinary Cancer

  • Recent Topics in Genitourinary Cancer

    _
    News Releases
    9/28/2023

    Study offers way to increase immune checkpoint inhibitor effectiveness in patients with MTAP-deleted cancers

    • Research
    • Melanoma
    • Bladder Cancer
    Eli Van Allen, MD
    News Releases
    9/19/2023

    Deep learning reveals valuable clues about kidney cancer in pathology slides

    • Kidney Cancer
    Retiring after several decades in financial services, Rubin enjoyed his "second career" running a hot dog cart for several years despite various health challenges.
    Insight Blog
    9/7/2023

    ​​​Retiree Relishing Life After Advanced Kidney Cancer Treatment 

    • Patient Stories, Adult
    • Kidney Cancer
    • Genitourinary Cancer
    Insight Blog
    7/18/2023

    Living Systematic Review Guides Prostate Cancer Treatment Options

    • Research
    • Prostate Cancer
    • Genitourinary Cancer
    Addressing the physical and emotional side effects of prostate cancer is a priority for care teams at Dana-Farber. 
    Insight Blog
    6/30/2023

    Navigating the Mental Health Toll of Prostate Cancer and Its Side Effects 

    • Prostate Cancer
    • Genitourinary Cancer
    Insight Blog
    6/29/2023

    Prostate Cancer Disparities Drive Quest for Equity 

    • Prostate Cancer
    • Genitourinary Cancer
    Judy E. Garber, MD, MPH
    Insight Blog
    6/26/2023

    What’s the Connection Between BRCA and Ashkenazi Jewish Ancestry? 

    • BRCA
    • Ovarian Cancer
    • Prostate Cancer
    • Genitourinary Cancer
    • Pancreatic Cancer
    • Gastrointestinal Cancer
    • Cancer Genetics
    • Breast Cancer
    Prostate Cancer Cells
    News Releases
    6/9/2023

    Treatment decisions in new era of individualized therapy for metastatic hormone-sensitive prostate cancer guided by Dana-Farber case study

    • Research
    • Prostate Cancer
    PD-L1 inhibitor at work blocking PD-L1 (red) from interacting with PD-1 (blue) on a T-cell. Credit: Getty Images
    News Releases
    6/5/2023

    Study sends strong signal not to sequence immune checkpoint inhibitors in advanced kidney cancer

    • Kidney Cancer